These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6310732)

  • 1. Cellular origin of the chemokinetic inhibitor of polymorphononuclear leucocytes found in sera from patients with chronic lymphocytic leukaemia.
    Siegbahn A; Venge P; Nilsson K
    Scand J Haematol; 1983 Aug; 31(2):184-92. PubMed ID: 6310732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia.
    Siegbahn A; Venge P; Nilsson K; Simonson B
    Scand J Haematol; 1982 Feb; 28(2):122-31. PubMed ID: 7046030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes.
    Siegbahn A; Rosén A; Venge P; Aman P; Nilsson K
    Leuk Res; 1986; 10(2):179-86. PubMed ID: 3485223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
    Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
    Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.
    Rickinson AB; Finerty S; Epstein MA
    Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a phorbol ester on activation and immortalization of leukaemic B cells by Epstein-Barr virus.
    Walls EV; Crawford DH
    Leuk Res; 1990; 14(4):389-91. PubMed ID: 2159092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokinetic inhibitory factor derived from chronic lymphocytic leukaemia cells. Partial purification and characterization of a new lymphokine.
    Siegbahn A; Nilsson K; Venge P
    Scand J Immunol; 1986 Jan; 23(1):15-23. PubMed ID: 3704559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and Epstein Barr virus (EBV) genes expression in blood chronic lymphocytic leukaemia (CLL) cells and their immortalised CLL cell lines.
    Laytragoon-Lewin N; Chen F; Castro J; Avila-Carino J; Lewin F
    Anticancer Res; 2003; 23(5A):4017-22. PubMed ID: 14666712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic, cytogenetic and molecular characterization of a new B-chronic lymphocytic leukaemia (B-CLL) cell line.
    Caligaris-Cappio F; Bergui L; Rege-Cambrin G; Tesio L; Migone N; Malavasi F
    Leuk Res; 1987; 11(7):579-88. PubMed ID: 3039258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
    Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
    Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokinetic inhibitory factor (CIF) in serum of CLL patients: correlation with infection propensity and disease activity.
    Siegbahn A; Simonsson B; Venge P
    Scand J Haematol; 1985 Jul; 35(1):80-7. PubMed ID: 3901243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of serum on random migration and chemotaxis of polymorphonuclear leucocytes: methodological evaluation using sera from infection-prone patients and normals.
    Håkansson L; Venge P
    Scand J Immunol; 1980; 11(3):271-82. PubMed ID: 9537055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines.
    Lewin N; Aman P; Mellstedt H; Zech L; Klein G
    Int J Cancer; 1988 Jun; 41(6):892-5. PubMed ID: 2836321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
    Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
    Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of a human B cell chronic lymphocytic leukemia line in nude mice.
    Ghose T; Lee CL; Faulkner G; Fernandez LA; Lee SH
    Am J Hematol; 1988 Jul; 28(3):146-54. PubMed ID: 2841846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.
    Aman P; Mellstedt H
    Leuk Res; 1991; 15(8):715-9. PubMed ID: 1654482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of B-cell mitogen-induced and spontaneous thymidine uptake in vitro in chronic B-lymphocytic leukaemia cells.
    Juliusson G; Robèrt KH; Nilsson B; Gahrton G
    Br J Haematol; 1985 Jul; 60(3):429-36. PubMed ID: 2410008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.